Skip to main content
Caplight Logo









MabGenesis株式会社

MabGenesis株式会社

Private
YokohamaHealthcare & Life Scienceshttps://mabgenesis.com/

Last Round

VC Round

Dec 24, 2024

Est. Valuation

$21.66M

Total Funding Raised

$2.57M

Company Overview

MabGenesis株式会社 is a Japanese biotechnology company that develops therapeutic monoclonal antibody drugs for humans and companion animals.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

monoclonal antibody therapyantibody discoveryveterinary antibodiescompanion animal healthdrug discovery platformanimal pharmaphage displaydrug licensingantibody librarydrug discovery partnershipmAbsmembrane protein targetscanine therapeuticsfeline therapeuticszoonotic diseases

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MabGenesis株式会社 Comparables

Compare MabGenesis株式会社 with similar companies based on industry and business-model similarity.

MabGenesis株式会社 comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vetigenics Inc.
80%
iBody Inc.
78%
MOLCURE Inc.
76%

MabGenesis株式会社 Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 24, 2024
VC RoundDec 2, 2022
Series A ExtensionJun 1, 2020
SeedJan 19, 2020

MabGenesis株式会社 Investors

Notable investors and investment history

MabGenesis株式会社 investors
InvestorRounds
Beyond Next VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 24, 2024

    $3M raised from venture capital and government investors.

  • Nov 13, 2024

    Monthly visitors increased 60% MoM.

MabGenesis株式会社 Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MabGenesis株式会社 Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MabGenesis株式会社's valuation, stock price, and market status.

Firmographic Details

HeadquartersYokohama
Employee Range3
Year Founded2019
Last FundingDec 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?